DOC Pharma: A New Identity for the Generic Drugs Company, Advancing Growth By Targeting Broader Pharmaceutical Market
DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the ...
Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor
New York [US]/ London [UK]/ Munich [Germany]/ New Delhi [India], February 11: Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as ...
A new vision is needed to tackle the drug crisis
Cutting government waste is a good aim, but we need a bold new vision and priorities to tackle the drug crisis.
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Despite “industry challenges,” national rating agencies maintain Ballad Health “A” ratings with “stable” outlook
Johnson City, Tennessee, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ballad Health announced today that, despite cited industry challenges for hospitals and health systems, the nation’s major ratings agencies ...
Study finds rare vision issues in taking GLP-1 weight loss drugs
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
The Trump administration restores federal webpages after court order
DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...
manilatimes6m
Genmab Publishes 2024 Annual Report
Genmab will hold a conference call to discuss the full year results for 2024 today, February 12, 2025, at 6:00 pm CET, 5:00 pm GMT, 12:00 pm EST. To join the call please use the below registration ...